Literature DB >> 33531698

Myocardial stunning and hibernation revisited.

Gerd Heusch1.   

Abstract

Unlike acute myocardial infarction with reperfusion, in which infarct size is the end point reflecting irreversible injury, myocardial stunning and hibernation result from reversible myocardial ischaemia-reperfusion injury, and contractile dysfunction is the obvious end point. Stunned myocardium is characterized by a disproportionately long-lasting, yet fully reversible, contractile dysfunction that follows brief bouts of myocardial ischaemia. Reperfusion precipitates a burst of reactive oxygen species formation and alterations in excitation-contraction coupling, which interact and cause the contractile dysfunction. Hibernating myocardium is characterized by reduced regional contractile function and blood flow, which both recover after reperfusion or revascularization. Short-term myocardial hibernation is an adaptation of contractile function to the reduced blood flow such that energy and substrate metabolism recover during the ongoing ischaemia. Chronic myocardial hibernation is characterized by severe morphological alterations and altered expression of metabolic and pro-survival proteins. Myocardial stunning is observed clinically and must be recognized but is rarely haemodynamically compromising and does not require treatment. Myocardial hibernation is clinically identified with the use of imaging techniques, and the myocardium recovers after revascularization. Several trials in the past two decades have challenged the superiority of revascularization over medical therapy for symptomatic relief and prognosis in patients with chronic coronary syndromes. A better understanding of the pathophysiology of myocardial stunning and hibernation is important for a more precise indication of revascularization and its consequences. Therefore, this Review summarizes the current knowledge of the pathophysiology of these characteristic reperfusion phenomena and highlights their clinical implications.

Entities:  

Mesh:

Year:  2021        PMID: 33531698     DOI: 10.1038/s41569-021-00506-7

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  213 in total

1.  Hibernation and stunning of the myocardium.

Authors:  R A Kloner; K Przyklenk
Journal:  N Engl J Med       Date:  1991-12-26       Impact factor: 91.245

Review 2.  Evolving therapies for myocardial ischemia/reperfusion injury.

Authors:  Borja Ibáñez; Gerd Heusch; Michel Ovize; Frans Van de Werf
Journal:  J Am Coll Cardiol       Date:  2015-04-14       Impact factor: 24.094

3.  Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs.

Authors:  G R Heyndrickx; R W Millard; R J McRitchie; P R Maroko; S F Vatner
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

Review 4.  Coronary bypass surgery for chronic angina--1981. A perspective.

Authors:  S H Rahimtoola
Journal:  Circulation       Date:  1982-02       Impact factor: 29.690

5.  Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation.

Authors:  G A Diamond; J S Forrester; P L deLuz; H L Wyatt; H J Swan
Journal:  Am Heart J       Date:  1978-02       Impact factor: 4.749

6.  Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis.

Authors:  P R Maroko; P Libby; W R Ginks; C M Bloor; W E Shell; B E Sobel; J Ross
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

7.  Clinical overview of management of chronic ischemic heart disease.

Authors:  S H Rahimtoola
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

Review 8.  A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina.

Authors:  S H Rahimtoola
Journal:  Circulation       Date:  1985-12       Impact factor: 29.690

Review 9.  The relationship between regional blood flow and contractile function in normal, ischemic, and reperfused myocardium.

Authors:  G Heusch
Journal:  Basic Res Cardiol       Date:  1991 May-Jun       Impact factor: 17.165

Review 10.  The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Authors:  E Braunwald; R A Kloner
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

View more
  14 in total

1.  Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function.

Authors:  Deanna K Sosnowski; K Lockhart Jamieson; Artiom Gruzdev; Yingxi Li; Robert Valencia; Ala Yousef; Zamaneh Kassiri; Darryl C Zeldin; John M Seubert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-08-19       Impact factor: 5.125

2.  Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor.

Authors:  Helmut Raphael Lieder; Maria Tsoumani; Ioanna Andreadou; Karsten Schrör; Gerd Heusch; Petra Kleinbongard
Journal:  Cardiovasc Drugs Ther       Date:  2022-05-21       Impact factor: 3.947

3.  Cardioprotection of Repeated Remote Ischemic Conditioning in Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Shaomin Chen; Shijia Li; Xinheng Feng; Guisong Wang
Journal:  Front Cardiovasc Med       Date:  2022-05-26

4.  Nuclear Tkt promotes ischemic heart failure via the cleaved Parp1/Aif axis.

Authors:  Zhiyan Wang; Zeping Qiu; Sha Hua; Wenbo Yang; Yanjia Chen; Fanyi Huang; Yingze Fan; Lingfeng Tong; Tianle Xu; Xuemei Tong; Ke Yang; Wei Jin
Journal:  Basic Res Cardiol       Date:  2022-04-05       Impact factor: 12.416

Review 5.  Myocardial injury, troponin release, and cardiomyocyte death in brief ischemia, failure, and ventricular remodeling.

Authors:  John M Canty
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-05-13       Impact factor: 5.125

6.  Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes.

Authors:  Helmut Raphael Lieder; Felix Braczko; Nilgün Gedik; Merlin Stroetges; Gerd Heusch; Petra Kleinbongard
Journal:  Basic Res Cardiol       Date:  2021-04-19       Impact factor: 17.165

Review 7.  Coronary blood flow in heart failure: cause, consequence and bystander.

Authors:  Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2022-01-13       Impact factor: 12.416

8.  Long non-coding RNA growth arrest specific transcript 5 acting as a sponge of MicroRNA-188-5p to regulate SMAD family member 2 expression promotes myocardial ischemia-reperfusion injury.

Authors:  Jin Xu; Dong Yu; Xiaolu Bai; Peng Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 9.  Myocardial oedema: pathophysiological basis and implications for the failing heart.

Authors:  Francisco Vasques-Nóvoa; António Angélico-Gonçalves; José M G Alvarenga; João Nobrega; Rui J Cerqueira; Jennifer Mancio; Adelino F Leite-Moreira; Roberto Roncon-Albuquerque
Journal:  ESC Heart Fail       Date:  2022-02-11

Review 10.  Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control.

Authors:  Xing Chang; Amanda Lochner; Hsueh-Hsiao Wang; Shuyi Wang; Hang Zhu; Jun Ren; Hao Zhou
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.